Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[In this work we report that subjects with activating KIR2DS1 and/or KIR2DS2 genes are susceptible to developing psoriatic arthritis, but only when HLA ligands for their homologous inhibitory receptors, KIR2DL1 and KIR2DL2/3, are missing.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP785803.RAfSJTFQzH_mD0IUMIRNUAupu9i6iHWWdQ982p5wfJ22M130_assertion description "[In this work we report that subjects with activating KIR2DS1 and/or KIR2DS2 genes are susceptible to developing psoriatic arthritis, but only when HLA ligands for their homologous inhibitory receptors, KIR2DL1 and KIR2DL2/3, are missing.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP785803.RAfSJTFQzH_mD0IUMIRNUAupu9i6iHWWdQ982p5wfJ22M130_provenance.
• NP475084.RAjHtT1sbsMq_FzRnDWWUnguu-IxfxuoYcPOmpLqQeOPg130_assertion description "[In this work we report that subjects with activating KIR2DS1 and/or KIR2DS2 genes are susceptible to developing psoriatic arthritis, but only when HLA ligands for their homologous inhibitory receptors, KIR2DL1 and KIR2DL2/3, are missing.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP475084.RAjHtT1sbsMq_FzRnDWWUnguu-IxfxuoYcPOmpLqQeOPg130_provenance.
• NP733705.RA6le1xEJvfUPOzBUQSYMQVeiyKJn7TdIIQA8CQvAR46o130_assertion description "[In this work we report that subjects with activating KIR2DS1 and/or KIR2DS2 genes are susceptible to developing psoriatic arthritis, but only when HLA ligands for their homologous inhibitory receptors, KIR2DL1 and KIR2DL2/3, are missing.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP733705.RA6le1xEJvfUPOzBUQSYMQVeiyKJn7TdIIQA8CQvAR46o130_provenance.
• NP514690.RAOo1q4rERxhHWRGfkPt4QJs5hFLMXra6YpXiwhhgjThE130_assertion description "[In this work we report that subjects with activating KIR2DS1 and/or KIR2DS2 genes are susceptible to developing psoriatic arthritis, but only when HLA ligands for their homologous inhibitory receptors, KIR2DL1 and KIR2DL2/3, are missing.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP514690.RAOo1q4rERxhHWRGfkPt4QJs5hFLMXra6YpXiwhhgjThE130_provenance.
• NP900649.RA16bUOSfrWIZT38l2DqHxKypv4hXQ7Z7eybcBEdAWdPk130_assertion description "[In this work we report that subjects with activating KIR2DS1 and/or KIR2DS2 genes are susceptible to developing psoriatic arthritis, but only when HLA ligands for their homologous inhibitory receptors, KIR2DL1 and KIR2DL2/3, are missing.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP900649.RA16bUOSfrWIZT38l2DqHxKypv4hXQ7Z7eybcBEdAWdPk130_provenance.
• NP936330.RA-DDJA71nCnuRXqiS8MTlKOBauhgdyV4Ymws4nuH_umY130_assertion description "[In this work we report that subjects with activating KIR2DS1 and/or KIR2DS2 genes are susceptible to developing psoriatic arthritis, but only when HLA ligands for their homologous inhibitory receptors, KIR2DL1 and KIR2DL2/3, are missing.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP936330.RA-DDJA71nCnuRXqiS8MTlKOBauhgdyV4Ymws4nuH_umY130_provenance.
• NP797652.RAF3tYHOfycmgQcMoi0Ri9hcCKxxd6gMHW7G2-62CglSs130_assertion description "[In this work we report that subjects with activating KIR2DS1 and/or KIR2DS2 genes are susceptible to developing psoriatic arthritis, but only when HLA ligands for their homologous inhibitory receptors, KIR2DL1 and KIR2DL2/3, are missing.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP797652.RAF3tYHOfycmgQcMoi0Ri9hcCKxxd6gMHW7G2-62CglSs130_provenance.
• NP524257.RAS_IVyIpiKjKQPhg9e7sRL_W8ml1MBkqIMtqvH8SfI-U130_assertion description "[In this work we report that subjects with activating KIR2DS1 and/or KIR2DS2 genes are susceptible to developing psoriatic arthritis, but only when HLA ligands for their homologous inhibitory receptors, KIR2DL1 and KIR2DL2/3, are missing.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP524257.RAS_IVyIpiKjKQPhg9e7sRL_W8ml1MBkqIMtqvH8SfI-U130_provenance.
• NP524424.RAYl3ru1VDx02KZm_9U2TmXLq9DAvtdN5akBQjSHe8x3Y130_assertion description "[In this work we report that subjects with activating KIR2DS1 and/or KIR2DS2 genes are susceptible to developing psoriatic arthritis, but only when HLA ligands for their homologous inhibitory receptors, KIR2DL1 and KIR2DL2/3, are missing.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP524424.RAYl3ru1VDx02KZm_9U2TmXLq9DAvtdN5akBQjSHe8x3Y130_provenance.
• NP965689.RA06IjNtgCryxpAY0ZjOqxIQCR7NK0EZiX4EC197D1L_c130_assertion description "[In this work we report that subjects with activating KIR2DS1 and/or KIR2DS2 genes are susceptible to developing psoriatic arthritis, but only when HLA ligands for their homologous inhibitory receptors, KIR2DL1 and KIR2DL2/3, are missing.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP965689.RA06IjNtgCryxpAY0ZjOqxIQCR7NK0EZiX4EC197D1L_c130_provenance.
• assertion description "[In this work we report that subjects with activating KIR2DS1 and/or KIR2DS2 genes are susceptible to developing psoriatic arthritis, but only when HLA ligands for their homologous inhibitory receptors, KIR2DL1 and KIR2DL2/3, are missing.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP367306.RA5D_XWr5-u-18EJlItQlrpOlxJpdjR9c7f-9Y0_5bkz8130_assertion description "[In this work we report that subjects with activating KIR2DS1 and/or KIR2DS2 genes are susceptible to developing psoriatic arthritis, but only when HLA ligands for their homologous inhibitory receptors, KIR2DL1 and KIR2DL2/3, are missing.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP367306.RA5D_XWr5-u-18EJlItQlrpOlxJpdjR9c7f-9Y0_5bkz8130_provenance.
• NP367310.RA1J2d5IW3HEyhGErYaa2rA-z8UzcedWxIQh8is1MIdHA130_assertion description "[In this work we report that subjects with activating KIR2DS1 and/or KIR2DS2 genes are susceptible to developing psoriatic arthritis, but only when HLA ligands for their homologous inhibitory receptors, KIR2DL1 and KIR2DL2/3, are missing.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP367310.RA1J2d5IW3HEyhGErYaa2rA-z8UzcedWxIQh8is1MIdHA130_provenance.
• NP524535.RAIwPPYw6KKgx-Uo_9VMm0A-0NfnEF9TNgPcNQMfDdztQ130_assertion description "[In this work we report that subjects with activating KIR2DS1 and/or KIR2DS2 genes are susceptible to developing psoriatic arthritis, but only when HLA ligands for their homologous inhibitory receptors, KIR2DL1 and KIR2DL2/3, are missing.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP524535.RAIwPPYw6KKgx-Uo_9VMm0A-0NfnEF9TNgPcNQMfDdztQ130_provenance.
• NP367304.RAXTIn1yZQP51ZRLLiV2se43u_w0o9hoBOeC-AhG19rBA130_assertion description "[In this work we report that subjects with activating KIR2DS1 and/or KIR2DS2 genes are susceptible to developing psoriatic arthritis, but only when HLA ligands for their homologous inhibitory receptors, KIR2DL1 and KIR2DL2/3, are missing.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP367304.RAXTIn1yZQP51ZRLLiV2se43u_w0o9hoBOeC-AhG19rBA130_provenance.
• NP367305.RAIX0XMlJYcOfIJnvShVn2DBMCNy3xQRzm5F_EjA-hNWs130_assertion description "[In this work we report that subjects with activating KIR2DS1 and/or KIR2DS2 genes are susceptible to developing psoriatic arthritis, but only when HLA ligands for their homologous inhibitory receptors, KIR2DL1 and KIR2DL2/3, are missing.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP367305.RAIX0XMlJYcOfIJnvShVn2DBMCNy3xQRzm5F_EjA-hNWs130_provenance.
• NP367308.RAMaANS79h_1kYIlDL39tIgMr0QAx9YISld1yspcFQg6A130_assertion description "[In this work we report that subjects with activating KIR2DS1 and/or KIR2DS2 genes are susceptible to developing psoriatic arthritis, but only when HLA ligands for their homologous inhibitory receptors, KIR2DL1 and KIR2DL2/3, are missing.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP367308.RAMaANS79h_1kYIlDL39tIgMr0QAx9YISld1yspcFQg6A130_provenance.
• NP367309.RAJe46jtX7rTRRYP2dN4sSul10FV2yOJVporsDlzaPqpA130_assertion description "[In this work we report that subjects with activating KIR2DS1 and/or KIR2DS2 genes are susceptible to developing psoriatic arthritis, but only when HLA ligands for their homologous inhibitory receptors, KIR2DL1 and KIR2DL2/3, are missing.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP367309.RAJe46jtX7rTRRYP2dN4sSul10FV2yOJVporsDlzaPqpA130_provenance.
• NP367311.RAPQotWVRy7tmgBQKPUUzn8kWLu4iiMT4-SudS7xAXkos130_assertion description "[In this work we report that subjects with activating KIR2DS1 and/or KIR2DS2 genes are susceptible to developing psoriatic arthritis, but only when HLA ligands for their homologous inhibitory receptors, KIR2DL1 and KIR2DL2/3, are missing.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP367311.RAPQotWVRy7tmgBQKPUUzn8kWLu4iiMT4-SudS7xAXkos130_provenance.
• assertion description "[In this work we report that subjects with activating KIR2DS1 and/or KIR2DS2 genes are susceptible to developing psoriatic arthritis, but only when HLA ligands for their homologous inhibitory receptors, KIR2DL1 and KIR2DL2/3, are missing.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP524313.RAvERr5VXn3Q-2w7cx4hQC5YaehkmpySWXF7Gq3S-IA1s130_assertion description "[In this work we report that subjects with activating KIR2DS1 and/or KIR2DS2 genes are susceptible to developing psoriatic arthritis, but only when HLA ligands for their homologous inhibitory receptors, KIR2DL1 and KIR2DL2/3, are missing.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP524313.RAvERr5VXn3Q-2w7cx4hQC5YaehkmpySWXF7Gq3S-IA1s130_provenance.
• NP929381.RAvVw7RsjVCn__BhfS3uWVdm2TEJGM_uHJNYQYmJW9EB4130_assertion description "[In this work we report that subjects with activating KIR2DS1 and/or KIR2DS2 genes are susceptible to developing psoriatic arthritis, but only when HLA ligands for their homologous inhibitory receptors, KIR2DL1 and KIR2DL2/3, are missing.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP929381.RAvVw7RsjVCn__BhfS3uWVdm2TEJGM_uHJNYQYmJW9EB4130_provenance.
• NP1012608.RAtT0z4rx4vF3Z-dqe6eU47czYdDD1Dwidj01lyuYVm3U130_assertion description "[In this work we report that subjects with activating KIR2DS1 and/or KIR2DS2 genes are susceptible to developing psoriatic arthritis, but only when HLA ligands for their homologous inhibitory receptors, KIR2DL1 and KIR2DL2/3, are missing.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1012608.RAtT0z4rx4vF3Z-dqe6eU47czYdDD1Dwidj01lyuYVm3U130_provenance.